Tarek Mouhieddine, MD
@tarekmd91
@AUB_Lebanon | @DanaFarber | @IcahnMountSinai | @SinaiHemeOnc Fellow @TischCancer | Physician-scientist #multiplemyeloma #myeloma #mmsm 🇱🇧🇺🇸
ID:385075225
https://www.linkedin.com/in/tarekmouhieddine 04-10-2011 20:39:40
1,2K Tweets
2,2K Followers
3,3K Following
We are one step closer to fully understanding and optimizing treatment with bispecific antibodies in #multiplemyeloma #mmsm ASH Icahn School of Medicine at Mount Sinai Mount Sinai Health System Mount Sinai Hematology/Oncology Fellowship JanssenUS Published by VJHemOnc vjhemonc.com/video/utkr5iar…
Genomic Classification and Individualized Prognosis in Multiple Myeloma #mmsm Francesco Maura Ola Landgren, M.D. Journal of Clinical Oncology
ascopubs.org/doi/10.1200/JC…
Individualized risk in NDMM (IRMMa) model
Nice work building on GEP (UAMS) and current risk systems
#ASH23 Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy. Higher baseline fibrinogen and ferritin were associated with inferior OS; higher baseline ALC associated with more ICANS #mmsm Tarek Mouhieddine, MD Joshua Richter ash.confex.com/ash/2023/webpr…
How to write a review simple enough to elucidate MM CAR-T for students/early-career HCWs while satisfactorily providing the latest updates on the field for Hem/Onc peeps? Well, it’s not easy… But me and
Norah Sadek, MD tried: doi.org/10.1002/cpt.30…
Check out our state-of-the-art…
Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation | Mount Sinai - New York shar.es/agX9Rx
#MultipleMyeloma Icahn School of Medicine at Mount Sinai Multiple Myeloma RF
Samir Parekh, MD; Brian Brown, PhD
Excited to share our review of CH and inflammation covering clinical applications, pre-clinical mechanisms, and next steps in the field. Thanks to co-authors at Mount Sinai Hematology/Oncology Fellowship and The Tisch Cancer Institute. Online now Critical Reviews in Oncology Hematology (CROH).
sciencedirect.com/science/articl…
Congratulations to Jon Anker, MD, PhD on receiving a Young Investigator Award from Society for Immunotherapy of Cancer. He is presenting at #SITC23 .
Matt Galsky Icahn School of Medicine at Mount Sinai Bhardwaj Lab
Just published - Effect of diabetes diagnosis on survival in myeloma! Grateful for this collaboration between MSK Department of Medicine & Dr Gallagher, Dr Parekh Mount Sinai Health System Blood Advances Saad Z. Usmani MD MBA FACP (he/his/him)🇺🇸🇵🇰 Joshua Richter Cesar Rodriguez, MD (Myelomatips.com) Malin Hultcrantz MD PhD
ashpublications.org/bloodadvances/… #mmsm #IMS23
More and more people are using the word “CURE” and “MULTIPLE MYELOMA” in the same sentence. Exciting times lie ahead!! #mmsm #multiplemyeloma #myeloma #IMS23 Myeloma Society #MedTwitter
🚨Thrilled to share our latest work on the immune implications of MTAP deletions, out now Cancer Cell
cell.com/cancer-cell/fu…
🤝Result of a collaboration between Brigham and Women’s Research Dana-Farber UT Austin. Co-lead w/ Donjeta Gjuka & senior authors David Kwiatkowski & Everett Stone
Congratulations to Dr. Sundar Jagannath The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai for receiving the Waldenstrom Lifetime Achievement Award in myeloma. Myeloma Society #IMS23
What an amazing journey and inspiring physician and human being!
Thank you for everything you do!